List of Taisho Pharmaceutical Co. patents

Patents where

Current Assignee

Name

‌

Taisho Pharmaceutical Co.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8729271 Glycine transporter inhibiting substances	Patent 8729271 was granted and assigned to Taisho Pharmaceutical Co. on May, 2014 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	8729271	May 20, 2014
‌ US Patent 7435590 Monoclonal antibody and hybridoma producing the same	Patent 7435590 was granted and assigned to Taisho Pharmaceutical Co. on October, 2008 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7435590	October 14, 2008
‌ US Patent 7439232 Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the same	Patent 7439232 was granted and assigned to Taisho Pharmaceutical Co. on October, 2008 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7439232	October 21, 2008
‌ US Patent 7414072 Aryl 5-thio-β-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the same	Patent 7414072 was granted and assigned to Taisho Pharmaceutical Co. on August, 2008 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7414072	August 19, 2008
‌ US Patent 7279584 Method for production of cis-4-fluoro-L-proline derivatives	Patent 7279584 was granted and assigned to Taisho Pharmaceutical Co. on October, 2007 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7279584	October 9, 2007
‌ US Patent 7304166 Benzenesulfonate salt of 4-fluoro-2-cyanopyrrolidine derivatives	Patent 7304166 was granted and assigned to Taisho Pharmaceutical Co. on December, 2007 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7304166	December 4, 2007
‌ US Patent 7250522 Method for selective preparation of aryl 5-thio-β-D-aldohexopyranosides	Patent 7250522 was granted and assigned to Taisho Pharmaceutical Co. on July, 2007 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7250522	July 31, 2007
‌ US Patent 9422240 Partially saturated nitrogen-containing heterocyclic compound	Patent 9422240 was granted and assigned to Taisho Pharmaceutical Co. on August, 2016 by the United States Patent and Trademark Office.	‌ Taisho Pharmaceutical Co.	‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	9422240	August 23, 2016
‌ US Patent 7393519 Base for oral composition and the oral composition	Patent 7393519 was granted and assigned to Taisho Pharmaceutical Co. on July, 2008 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7393519	July 1, 2008
‌ US Patent 7157594 6-Fluorobicyclo[3.1.0]hexane derivatives	Patent 7157594 was granted and assigned to Taisho Pharmaceutical Co. on January, 2007 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7157594	January 2, 2007
‌ US Patent 7381746 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative	Patent 7381746 was granted and assigned to Taisho Pharmaceutical Co. on June, 2008 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7381746	June 3, 2008
‌ US Patent 7932259 Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group	Patent 7932259 was granted and assigned to Taisho Pharmaceutical Co. on April, 2011 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7932259	April 26, 2011
‌ US Patent 7888354 Phenylpyrazole derivatives	Patent 7888354 was granted and assigned to Taisho Pharmaceutical Co. on February, 2011 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7888354	February 15, 2011
‌ US Patent 8461329 Isoquinoline derivative	Patent 8461329 was granted and assigned to Taisho Pharmaceutical Co. on June, 2013 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	8461329	June 11, 2013
‌ US Patent 8455511 Pyrrolopyridine derivatives substituted with cyclic amino group	Patent 8455511 was granted and assigned to Taisho Pharmaceutical Co. on June, 2013 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	8455511	June 4, 2013
‌ US Patent 8623898 Glycine transporter inhibiting substances	Patent 8623898 was granted and assigned to Taisho Pharmaceutical Co. on January, 2014 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	8623898	January 7, 2014
‌ US Patent 9522914 Azole derivative	Patent 9522914 was granted and assigned to Taisho Pharmaceutical Co. on December, 2016 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	9522914	December 20, 2016
‌ US Patent 7183322 Remedy for hypertension	Patent 7183322 was granted and assigned to Taisho Pharmaceutical Co. on February, 2007 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7183322	February 27, 2007
‌ US Patent 7994204 Binding inhibitor of sphingosine-1-phosphate	Patent 7994204 was granted and assigned to Taisho Pharmaceutical Co. on August, 2011 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7994204	August 9, 2011
‌ US Patent 8022091 Triazole derivative	Patent 8022091 was granted and assigned to Taisho Pharmaceutical Co. on September, 2011 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	8022091	September 20, 2011
‌ US Patent 9320727 Combinations of SGLT 2 inhibitors and antihypertensive drugs	Patent 9320727 was granted and assigned to Taisho Pharmaceutical Co. on April, 2016 by the United States Patent and Trademark Office.	‌ Taisho Pharmaceutical Co.	‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	9320727	April 26, 2016
‌ US Patent 10207976 Method for producing optically active 2-(2-fluorobiphenyl-4-yl) propanoic acid	Patent 10207976 was granted and assigned to Taisho Pharmaceutical Co. on February, 2019 by the United States Patent and Trademark Office.	‌ Taisho Pharmaceutical Co.	‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	10207976	February 19, 2019
‌ US Patent 9035059 Nitrogen-containing condensed heterocyclic compound	Patent 9035059 was granted and assigned to Taisho Pharmaceutical Co. on May, 2015 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	9035059	May 19, 2015
‌ US Patent 7214714 20-hydroxyeicosatetraenoic acid production inhibitors	Patent 7214714 was granted and assigned to Taisho Pharmaceutical Co. on May, 2007 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	7214714	May 8, 2007
‌ US Patent 8115017 C-phenyl 1-thioglucitol compound	Patent 8115017 was granted and assigned to Taisho Pharmaceutical Co. on February, 2012 by the United States Patent and Trademark Office.		‌ Taisho Pharmaceutical Co.	United States Patent and Trademark Office	8115017	February 14, 2012

Results per page:

83 results

0 selected

83 results

0 selected